Does Metabolic Tumor Volume Predict Tumor Regression Grade After Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer? - Jin, W.; Mellon, E.A.; Hoffe, S.E.; Frakes, J.M.; Springett, G.M.; Centeno, B.A.; Kim, R.; Mahipal, A.; Pimiento, J.M.; Malafa, M.P.; Latifi, K. (International Journal of Radiation Oncology, Biology, Physics, 2016)